Clinical relevance analysis also indicated that high expression of CCL15 or the M2-like macrophage marker CD163 predict a poor prognosis of HCC and the combined predictive value of CCL15 and CD163 in the prognosis is superior to that using either marker alone. Here, CD163 is linked to hepatocellular carcinoma.